Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|May 26, 2017
Preventing relapse after haematopoietic stem cell transplantation for acute leukaemia: the role of post-transplantation minimal residual disease (MRD) monitoring and MRD-directed interventionXiao-Dong Mo, Meng Lv, Xiao-Jun Huang
Shanghai Kou Qiang Yi Xue = Shanghai Journal of Stomatology|July 23, 2004
[Comparison of the results in 59 patients with mandibular fractures treated by internal rigid fixation and inter maxillary ligation]Xin-Feng Wen, Xiao-Dong Mo, Yue-Jian Ou
Annals of Hematology|September 28, 2025
Treatment of transplantation-associated thrombotic microangiopathy with iptacopan: two cases reportJun Kong, Ze Tian, Dao-Xing Deng, et al.
Blood Science (Baltimore, Md.)|January 12, 2024
Efficacy and safety of letermovir prophylaxis for cytomegalovirus infection after hematopoietic stem cell transplantationWen-Wen Li, Yong-Mei Zhang, Meng-Zhu Shen, et al.
Frontiers in Immunology|August 22, 2022
Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysisShuang Fan, Wen-Xuan Huo, Yang Yang, et al.
Science Bulletin|January 19, 2023
Optimizing antithymocyte globulin dosing in haploidentical hematopoietic cell transplantation: long-term follow-up of a multicenter, randomized controlled trialYu Wang, Qi-Fa Liu, Ren Lin, et al.
International Immunopharmacology|August 21, 2020
Valproic acid enhances pamidronate-sensitized cytotoxicity of Vδ2+ T cells against EBV-related lymphoproliferative cellsHaitao Gao, Ruoyang Liu, Ning Wu, et al.
The Journal of Surgical Research|July 7, 2009
Laparoscopic exploration of common bile duct with primary closure versus T-tube drainage: a randomized clinical trialWei-Jie Zhang, Gui-Fang Xu, Guo-Zhong Wu, et al.
Journal of Blood Medicine|March 23, 2026
Empiric Imipenem/Cilastatin/Relebactam for Febrile Neutropenia After Allogeneic Hematopoietic Stem Cell Transplantation: Two Case ReportsDao-Xing Deng, Ting Wang, Hui Sun, et al.
Translational Oncology|July 12, 2021
Targeting IFN-γ-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damageLi-Ting Niu, Yu-Qing Wang, Catherine C L Wong, et al.
Pageof 20